Key Insights

Highlights

Success Rate

80% trial completion

Published Results

12 trials with published results (22%)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

10.9%

6 terminated out of 55 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

50%

12 of 24 completed with results

Key Signals

12 with results80% success

Data Visualizations

Phase Distribution

42Total
Not Applicable (22)
Early P 1 (1)
P 1 (4)
P 2 (12)
P 3 (1)
P 4 (2)

Trial Status

Completed24
Recruiting11
Terminated6
Active Not Recruiting5
Unknown3
Withdrawn3

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (55)

Showing 20 of 20 trials
NCT06075953Phase 2RecruitingPrimary

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

NCT06868238Phase 2RecruitingPrimary

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)

NCT07527468Not ApplicableNot Yet Recruiting

HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery

NCT02928978Phase 2CompletedPrimary

Ruxolitinib for Premalignant Breast Disease

NCT07408856Phase 1Not Yet RecruitingPrimary

CAN1012 in Pre-Malignant DCIS and LCIS

NCT06902311Phase 2Recruiting

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

NCT06133647CompletedPrimary

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

NCT07492043Not Yet Recruiting

Breast Tumour Size Measurement by Field Cycling Imaging

NCT07478016Recruiting

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

NCT06218303Phase 1RecruitingPrimary

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

NCT02926911Not ApplicableActive Not Recruiting

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS

NCT00757302Phase 3Completed

Intraoperative Gamma Camera for Breast Cancer Surgery

NCT06903468Not ApplicableRecruitingPrimary

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

NCT07095114Not ApplicableRecruitingPrimary

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

NCT06033092Phase 2Active Not Recruiting

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion

NCT03216421Not ApplicableActive Not Recruiting

Intraoperative Radiation Therapy (IORT) in DCIS

NCT00605982Not ApplicableCompleted

Breast MRI as a Preoperative Tool for DCIS

NCT01644669Not ApplicableActive Not Recruiting

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®

NCT04365114Completed

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening

NCT03375892Not ApplicableCompleted

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

Scroll to load more

Research Network

Activity Timeline